News Releases

Moffitt Researchers Discover Two-Pronged Approach to Stimulate STING Antitumor Activity

Inhibition of methylation augments STING agonist drug antitumor activity

New Smoking Cessation Intervention Helps Patients with Cervical Cancer Precursor or Cervical Cancer Quit Smoking

MAPS smoking cessation intervention results in greater than two-fold increase in smoking abstinence

Gut Microbiome Influences How Lymphoma Patients Respond to CAR T Therapy

Moffitt study finds antibiotic treatment and different types of microorganisms can impact chimeric antigen receptor T-cell therapy outcomes

Magrolimab Plus Azacitidine Results in Promising Activity in Higher-Risk MDS Patients

Phase 1b trial results show the combo therapy has manageable toxicity and encouraging responses for patients, including those with difficult to treat...

Neoadjuvant Pembrolizumab Administered Before Surgery Improves Outcomes of Melanoma Patients

Phase 2 clinical trial results show the neoadjuvant-adjuvant therapeutic approach improves event-free survival in high-risk melanoma patients

Moffitt Cancer Center Recognized on Forbes America’s Best Large Employers List

Work-life balance, wellness reward, education assistance and more available to team members

Batter Up for Moffitts 15th-Annual Spring Swing Sun Safety Tour Offering Free Screenings at Florida Ballparks

Moffitt Cancer Center Partners with IBA for Proton Therapy

Speros FL, Moffitt’s 775-acre Pasco County Global Innovation Center, to house groundbreaking cancer treatment

Moffitt Cancer Center Names 3 New Research Leaders

Moffitt Researchers Discover New Pathways to Activate Dendritic Cells, Produce Strong Anti-Tumor Immunity

Oncolytic virus expressing CD40 ligand and IFNβ reduces tumor size, activates immune cells in phase 1 trial

Oncolytic Virus Treatment Produces Promising Results in Patients with Triple-Negative Breast Cancer

In a Moffitt phase 2 trial, talimogene laherparepvec plus neoadjuvant chemotherapy provided strong responses and immune cell activation

Moffitt’s Dr. Vani Simmons Honored with ASPO’s Joseph W. Cullen Memorial Award

American Society of Preventive Oncology recognizes those who have made lasting impacts on tobacco control efforts and interventions

Moffitt Cancer Center Names Kelley Gonzalvo as the new Chief Nursing Officer

Stereotactic Body Radiotherapy Is an Effective Treatment for Patients with Lung Neuroendocrine Tumors

Moffitt study shows this approach is effective for this rare tumor

Moffitt Cancer Center Joins Weill Cornell Medicine and University of North Carolina to Improve HIV-Related Cancer Care Abroad

The institutions received a $3.5 million grant from the National Cancer Institute to support their work